Advertisement

Topics

Companies Related to "Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome" [Most Relevant Company Matches] RSS

00:26 EST 19th February 2019 | BioPortfolio

Here are the most relevant search results for "Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome" found in our extensive corporate database of over 50,000 company records.

Showing "Independent Studies Dextromethorphan Donepezil Hydrochloride Rett Syndrome" Companies 1–25 of 2,600+

Extremely Relevant

The International Rett Syndrome Foundation

While there are over 3,800 known cases of Rett Syndrome in the United States which predominantly strikes only girls, the disorder is genetically linked to more widespread neurological disorders such as autism and schizophrenia. Rett symptoms begin to manifest between the first six to eighteen months of life and in most cases will eventually incapacitate the afflicted children so that they can...


International Rett Syndrome Foundation

Rett syndrome (RTT), a brain disorder affecting development in childhood, has been identified almost exclusively in females. RTT results in severe movement and communication problems following apparently normal development for the first six months of life. The characteristic features include loss of speech and purposeful hand use, occurrence of repetitive hand movements, abnormal walking, abnorm...

Relevant

Research Down Syndrome

Research Down Syndrome (RDS) is a non-profit foundation which funds research at leading institutions directed towards identifying safe and effective biomedical therapies to treat the intellectual difficulties associated with Down syndrome. RDS' mission is to educate and inspire society to fund and support Down syndrome cognitive research to enhance and expand life opportunities, helping people wit...


Sjogren's Syndrome Foundation

Founded in 1983, the Sjogren's Syndrome Foundation (SSF) provides patients with practical information and coping strategies that minimize the effects of Sjogren's syndrome. In addition, the Foundation is the clearinghouse for medical information and is the recognized national advocate for Sjogren's syndrome. The Foundation's mission is to educate patients and their families about Sjogren's syndrom...

Hallux Incorporated

Hallux is developing an investigational micro-insert for subungual delivery and treatment of distal lateral subungual onychomycosis. The dosage form is biodegradable and delivers high concentrations of terbinafine hydrochloride directly and selectively to the site of infection over a period of time. Results from pilot studies are encouraging and suggest th...

Global Down Syndrome Foundation

The Global Down Syndrome Foundation is a public non-profit 501(c)(3) dedicated to significantly improving the lives of people with Down syndrome through research, medical care, education, and advocacy. Formally established in 2009, the Foundation’s primary focus is to support the Linda Crnic Institute for Down Syndrome, the first academic home in the ...

Newron Pharmaceuticals S.p.A.

Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain. The Company is headquartered in Bresso near Milan, Italy. In addition to Xadago® for Parkinson’s disease, Newron has a strong pipeline of promising treatments for rare disease patie...

ConSynance Therapeutics, Inc.

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. The company’s pipeline includes innovative treatments for nonalcoholic steatohepatitis (NASH), the orphan disease Prader-Willi syndrome, and irritable bowel syndrome. ConSynance are collaborating with Chengdu SciMount Pharmatech Co., Ltd., a drug discov...

Angelman Syndrome Foundation

Since 1996, the Angelman Syndrome Foundation has funded 59 research grants totaling more than $3.5 million. The Angelman Syndrome Foundation has awarded a majority of these funds ($3.3 million) beginning in 2005. For more information on the Foundation, please visit www.angelman.org.

Berzelius Clinical Research Center

Berzelius Clinical Research Center AB (BCRC) is a unique Site Management Organisation specialised in clinical conduct of Phase 0/I/II studies and the ideal partner for Contract Research Organisations (CRO) and pharmaceutical companies. BCRC has a hospital based well-equipped clinical pharmacology unit. Having a fully trained critical care staff enables easy setup of invasive techniques and procedu...

GelTex Incorporated

We are dedicated to having a positive effect on the lives of people living with illness and disease. We have demonstrated this by bringing important new therapies from discovery to market. GelTex’s first product, Renagel® brand sevelamer hydrochloride, was granted marketing approval by the U.S. Food and Drug Administration (FDA) in October 1998 for the reduction of serum phosphorus in hemodialy...

LARIME

LARIME is an independent CRO founded in 1986 specialised in clinical studies, bioassay, data management, statistics, medical writing and observational studies.These activities take place in a GCP and GLP environment. The laboratory has obtained from the French Agency, the A grading for its degree of compliance with GLP.

OPTIMED Clinical Research

OPTIMED Clinical Research is an independent company, which offers its experience for phase I to phase IV studies and surveys.Located in Grenoble, France since 1990, OPTIMED Clinical Research has led numerous clinical studies on behalf of the pharmaceutical and agro-food industry.Making your constraints its own, OPTIMED Clinical Research has set up an efficient organization for your studies : adher...

Progenix Research Sdn Bhd

Progenix Research is an independent contract research organisation offering toxicology services to the world-wide pharmaceutical, biotechnology, agrochemical and industrial chemical industries.Progenix Research Sdn Bhd is a newly formed, independent contract research organisation with laboratory facilities currently under construction in Penang, Malaysia. A high quality, yet cost-efficient service...

Down Syndrome Association of Los Angeles

Who: Down Syndrome Association of Los Angeles (DSALA) with National Down Syndrome Society Buddy Walk® Spokesperson John C. McGinley, Dr. Cox on the ABC’s SCRUBS; Grand Marshal, Dr. Jim Sears of THE DOCTORS; Honoring Ken Jenkins, Dr. Kelso of SCRUBS with the Buddy Award, Emcees Mark Wallengren and Kristin Cruz of KOST’s Morning Show, a live dan...

ConSynance Therapeutics Inc.

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. ConSynance’s pipeline includes innovative treatments for NASH, the orphan disease Prader-Willi syndrome, and irritable bowel syndrome. www.consynance.com

EnzymeRx, LLC

EnzymeRx, LLC is a private, clinical stage biotechnology company developing enzyme-based therapeutics. Our lead product pegsitacase is in phase 1 clinical studies and being developed for the treatment of refractory gout, treatment and prophylaxis of tumor lysis syndrome, and other indications, and we are actively building our preclinical pipeline. For more...

CIT

CIT is an independent contract research organization specializing in animal safety studies. Its animal research program was awarded "Full Accreditation" by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International. CIT, prides itself in conducting quality in-life studies while assuring they go that extra step to achieve excellence in animal care and human co...

Center for Carpal Tunnel Studies

The Center for Carpal Tunnel Studies was established in1993 in Paradise Valley, Arizona by Dr. Benjamin M. Sucher. Since its inception, the Center has treated thousands of individuals and is continually engaged in documentation of clinical findings. The patient pool consists of individuals referred by outside medical providers as well as large numbers of individuals who have seen, read, or heard o...

Foundation for Angelman Syndrome Therapeutics (FAST)

Angelman Syndrome (AS) was first described by Dr. Harry Angelman in 1965. Common symptoms include developmental delay and intellectual disabilities, happy demeanor, movement and balance disorder, severe sleep disorders, seizures and limited speech. Most children are diagnosed between the ages of 3-5 but early detection and intervention can make a significant difference in the child's development ...

Betagenon AB

Betagenon has secured a strong, proprietary technology platform based upon the extensive research expertise on type 2 diabetes disease mechanisms established by the Founders, leading experts in the field. Betagenon's vision is to become a frontier company that delivers new smart drug platform solutions to the pharmaceutical industry for treatment of the metabolic syndrome and diabetes type 2. Afte...

Schulman Associates IRB

Schulman Associates Institutional Review Board, Inc. ("Schulman") is an independent IRB that has more than 25 years of experience in reviewing research protocols and consent documents to evaluate compliance with relevant regulations and ethical guidelines. As an independent IRB, Schulman is not part of an institution such as an academic medical center or hospital. Schulman can provide IRB services...

Novum Pharmaceutical Research Services

For over 25 years, Novum has been a world leader in the conduct of clinical trials and equivalency studies. We have completed over 2,000 studies with over 36,000 participants for more than 200 pharmaceutical companies. In the past year, we have paid over $3.3 million to individuals who have done studies.There are three locations from which you can participate in studies - Pittsburgh, PA; Houston, ...

Tetra Discovery Partners Inc.

Tetra Discovery Partners is a clinical stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Alzheimer's disease, neuro-developmental conditions such as Fragile X syndrome, traumatic brain injury, and other brain disorders. Tetra uses structure-guided drug design to discover m...

Northwest Kinetics Incorporated

Northwest Kinetics is an independent research facility which specializes in Phase I and Phase II clinical pharmaceutical studies. Northwest Kinetics provides a full range of services for both short and long-term Phase I and II trials. Our services can include review of protocol design, pharmacokinetic consultation, patient recruitment, study execution, data management and record keeping, and repor...


More From BioPortfolio on "Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks